CollPlant Biotechnologies Ltd.
CLGN
$1.47
-$0.03-2.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -17.47M | -7.50M | -7.02M | |
| Total Depreciation and Amortization | -- | 1.10M | 1.10M | 1.10M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | 2.03M | 1.93M | 2.31M | |
| Change in Net Operating Assets | -- | 11.60M | 1.91M | 848.00K | |
| Cash from Operations | -- | -2.75M | -2.57M | -2.76M | |
| Capital Expenditure | -- | -756.00K | -891.00K | -954.00K | |
| Sale of Property, Plant, and Equipment | -- | 68.00K | 68.00K | 68.00K | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -268.00K | -270.00K | -270.00K | |
| Cash from Investing | -- | -956.00K | -1.09M | -1.16M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 225.00K | 314.00K | 1.11M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | 225.00K | 314.00K | 1.11M | |
| Foreign Exchange rate Adjustments | -- | -176.00K | -220.00K | -379.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -3.66M | -3.57M | -3.19M | |